Results 201 to 210 of about 59,839 (262)

Hepatitis B vaccination in Chinese infants (2002-2006, Guangdong): long-term effectiveness in adulthood and biological features of HBV infection. [PDF]

Front Immunol
Liao Q, Liu B, Liao F, Xu R, Wang M, Shan Z, Huang J, Zhong H, Fu Y, Liang H, Rong X.   +10 more
europepmc   +1 more source

Prevalence of hepatitis B surface antibodies and hepatitis B exposure in Belgium: results from a nationwide population-based serosurvey. [PDF]

BMC Infect Dis
Furquim d'Almeida A, Ho E, Beutels P, Maertens K, Hens N, Van Damme P, Theeten H, Vanwolleghem T.   +7 more
europepmc   +1 more source

Hepatitis B virus RNA and hepatitis B surface antigen kinetics predict treatment outcomes in children with chronic hepatitis B. [PDF]

Front Cell Infect Microbiol
Peng X, Chang Y, Wu J, Zhu J, Hu P, Ren H, Xu H, Zhao R, Qin T.   +8 more
europepmc   +1 more source

Protein Priming Followed by a Replication-Competent VSV-GP Vector Boost Induces Sustained Immune Control in Therapeutic Hepatitis B Vaccination. [PDF]

Vaccines (Basel)
Su J, Kosinska AD, Miko S, Ates Öz E, Laer DV, Kimpel J, Protzer U.   +6 more
europepmc   +1 more source

Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response. [PDF]

Front Immunol
Kerth HA, Kächele M, Müller N, Singh S, Tulessin M, Sacherl J, Ates Öz E, Su J, Bester R, Miko S, Steiger K, Mogler C, Busch DH, Wettengel JM, Protzer U, Kosinska AD.   +15 more
europepmc   +1 more source

Seroprevalence and Demographic Distribution of Blood-Borne Viral Infections among Hemodialysis Patients in Sudan: A Multicenter Study from Conflict-Affected Khartoum State. [PDF]

Virol J
Azhary A, Mohammed A, Almomen M, Hajhamed NM, Kabashi M, Mahgoub EAA, Muvunyi CM, Ahmed M, Alharbi BF, Siddig EE.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Correlation of the Hepatitis B Surface and E Antigens

New England Journal of Medicine, 1978
D Y, Chien, G N, Vyas
openaire   +4 more sources

Hepatitis B Surface Antigen Levels Are Related to Spontaneous Hepatitis B Surface Antigen Seroconversion in Inactive Hepatitis B Carriers

Journal of Clinical Gastroenterology, 2020
Background: The cure for hepatitis B is defined as the hepatitis B surface antigen (HBsAg) seroclearance and/or seroconversion. Predictors of spontaneous seroconversion are not well described. The objective of this study is to identify predictors of spontaneous HBsAg seroconversion from community practice.
Crystal F, Wu, Tiffany M, Fong, Steven S, Wu, Sammy, Saab   +3 more
openaire   +2 more sources

Use of Pre-S Protein-Containing Hepatitis B Virus Surface Antigens and a Powerful Adjuvant To Develop an Immune Therapy for Chronic Hepatitis B Virus Infection [PDF]

Vaccine Journal, 2012
A hepatitis B virus (HBV) vaccine has been developed using a new adjuvant and HBV surface antigens produced from a CHO cell line. The purified HBV surface antigens are composed of L protein, M protein, and S protein in a mixture of 20- and 40-nm-diameter
Jaeseung Yoon, John Morrey, Young Chul Sung   +2 more
exaly   +4 more sources